RAPT Therapeutics (RAPT) Assets Average: 2020-2024
Historic Assets Average for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $117.8 million.
- Therapeutics' Assets Average fell 43.96% to $117.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $117.8 million, marking a year-over-year decrease of 43.96%. This contributed to the annual value of $219.8 million for FY2023, which is 5.44% down from last year.
- According to the latest figures from Q3 2024, Therapeutics' Assets Average is $117.8 million, which was down 16.73% from $141.5 million recorded in Q2 2024.
- In the past 5 years, Therapeutics' Assets Average ranged from a high of $257.3 million in Q1 2023 and a low of $112.4 million during Q1 2021.
- For the 3-year period, Therapeutics' Assets Average averaged around $196.7 million, with its median value being $204.8 million (2022).
- In the last 5 years, Therapeutics' Assets Average surged by 71.72% in 2022 and then crashed by 43.96% in 2024.
- Quarterly analysis of 5 years shows Therapeutics' Assets Average stood at $124.0 million in 2020, then surged by 67.82% to $208.0 million in 2021, then grew by 14.32% to $237.8 million in 2022, then decreased by 21.58% to $186.5 million in 2023, then tumbled by 43.96% to $117.8 million in 2024.
- Its last three reported values are $117.8 million in Q3 2024, $141.5 million for Q2 2024, and $164.6 million during Q1 2024.